Ferritinemia during type 1 Gaucher disease: mechanisms and progression under treatment

Blood Cells, Molecules & Diseases
Arsene MekinianChristian Rose

Abstract

Earlier results highlighted hyperferritinemia during type-1 Gaucher disease (GD), but its potential mechanisms and long-term progression remained unexamined. We analyzed the clinical, biological and iron characteristics of type-1 GD patients, before and after starting enzyme-replacement therapy (ERT). Iron parameters under ERT were subjected to linear-regression analyses. Serum ferritin (median 739 [46-2371] μg/L) was determined for 54 patients (21 (39%) males; median age 32 [range 12-73] years) before ERT; it exceeded 300 μg/L in 47 (87%), while the other iron parameters always remained normal: transferrin saturation coefficient (26 [16-42]), serum iron at 13 [6-22] mmol/L and transferrin at 2.4 [2,3] g/L. Four patients had mild elevation of liver transaminases, with C-reactive protein >20mg/l in two. The absence of hemolysis was accompanied by a median bilirubin of 9 μmol/L and lactate dehydrogenase at 250 IU/L; diabetes and lipid anomalies were not observed. Clinical, biological and iron parameters at GD diagnosis were comparable for the 12 and 42 patients with ferritinemia ≤400 and >400 μg/L, respectively. Ferritinemia was measured at least once for 46 patients after ERT onset (median treatment duration 90 [3-204] months). ...Continue Reading

References

Jun 11, 1983·British Medical Journal·M A MorganS Knowles
Jul 28, 2007·British Journal of Haematology·Ernest Beutler
Jul 28, 2007·British Journal of Haematology·Derralynn HughesCarla Hollak
Aug 11, 2010·Arthritis Research & Therapy·Jérôme StirnemannFrance Mentré
Oct 5, 2010·Annual Review of Medicine·Tomas Ganz, Elizabeta Nemeth
Nov 19, 2010·Blood Cells, Molecules & Diseases·Jérôme StirnemannNadia Belmatoug

❮ Previous
Next ❯

Citations

Oct 31, 2012·Current Opinion in Hematology·Derralynn A Hughes, Gregory M Pastores
Mar 20, 2014·Metallomics : Integrated Biometal Science·Stefanie Pfaender, Andreas M Grabrucker
Jan 30, 2013·Blood Cells, Molecules & Diseases·Cécile BraudeauAgathe Masseau
Dec 5, 2012·British Journal of Haematology·Kai Lehmberg, Stephan Ehl
Oct 5, 2013·European Journal of Internal Medicine·Elena CassinerioErika Poggiali
Jun 3, 2015·European Journal of Haematology·Irene MottaUNKNOWN Splenomegaly Gaucher Disease study group
Feb 3, 2015·La Revue de médecine interne·B LorcerieB Bonnotte
Nov 7, 2016·Blood Cells, Molecules & Diseases·Fryderyk LorenzMaciej Machaczka
Mar 24, 2016·Genetics and Molecular Biology·Tiago KoppeIda Vanessa D Schwartz
Apr 20, 2018·British Journal of Haematology·Jonathan O CullisUNKNOWN British Society for Haematology
Feb 22, 2017·International Journal of Molecular Sciences·Jérôme StirnemannMarc G Berger
Feb 12, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·Jasmin GalperRoy N Alcalay
Jan 15, 2019·La Revue de médecine interne·Y NguyenN Belmatoug
Nov 16, 2016·Blood Cells, Molecules & Diseases·Tomer AdarAri Zimran

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Blood Cells, Molecules & Diseases
Jérôme StirnemannNadia Belmatoug
American Journal of Hematology
Philip SteinPramod K Mistry
European Journal of Obstetrics, Gynecology, and Reproductive Biology
Sorina Granovsky-GrisaruAri Zimran
Blood Cells, Molecules & Diseases
Eli Ben ChetritAri Zimran
© 2021 Meta ULC. All rights reserved